Virus NAT for HIV, HBV, and HCV in Post-Mortal Blood Specimens over 48 h after Death of Infected Patients – First Results
暂无分享,去创建一个
S. Polywka | T. Meyer | B. Wulff | U. Kalus | A. Schröder | C. Edler | I. Wilkemeyer | A. Pruß
[1] S. Polywka,et al. A prospective time-course study on serological testing for human immunodeficiency virus, hepatitis B virus and hepatitis C virus with blood samples taken up to 48 h after death. , 2011, Journal of medical microbiology.
[2] L. Kucirka,et al. Risk of Window Period Hepatitis‐C Infection in High Infectious Risk Donors: Systematic Review and Meta‐Analysis , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[3] L. Kucirka,et al. High infectious risk donors: what are the risks and when are they too high? , 2011, Current opinion in organ transplantation.
[4] K. Ellingsona,et al. Estimated Risk of Human Immunodeficiency Virus and Hepatitis C Virus Infection among Potential Organ Donors from 17 Organ Procurement Organizations in the United States , 2011 .
[5] D. Krüger,et al. Tissue donation and virus safety: more nucleic acid amplification testing is needed , 2010, Transplant infectious disease : an official journal of the Transplantation Society.
[6] Michael P Busch,et al. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus , 2008, Transfusion.
[7] R. Seitz,et al. Effect of viral nucleic acid testing on contamination frequency of manufacturing plasma pools , 2008, Transfusion.
[8] J. Pawlotsky,et al. Serological Viral Testing of Cadaveric Cornea Donors , 2006, Transplantation.
[9] S. Kleinman,et al. Assessing the impact of HBV NAT on window period reduction and residual risk. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[10] P. Patel,et al. Transmission of Hepatitis C Virus to Several Organ and Tissue Recipients from an Antibody-Negative Donor , 2005, Annals of Internal Medicine.
[11] S. Glynn,et al. A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors , 2005, Transfusion.
[12] J. Trotter. Transmission of hepatitis C by implantation of a processed bone graft. A case report. , 2003, The Journal of bone and joint surgery. American volume.
[13] L. Rostaing,et al. Screening of blood from potential organ and cornea donors for viruses , 2002, Journal of medical virology.
[14] S. Kleinman,et al. Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseases , 2000 .
[15] S. Kleinman,et al. Committee report. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: Report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors. , 2000, Transfusion.
[16] A. Heim,et al. Evaluation of serological screening of cadaveric sera for donor selection for cornea transplantation , 1999, Journal of medical virology.
[17] W. Köhler. MiQ: Qualitatsstandards in der mikrobiologisch-infektiologischen Diagnostik. Gustav Fischer Verlag, Villanova Pa. (1997), Ringordner, DM 98.- , 1998 .
[18] C. Delloye,et al. Polymerase chain reaction in cadaveric blood and tissues. , 1996, Transplantation proceedings.
[19] J. Pepose,et al. New developments in serologic screening of corneal donors for HIV-1 and hepatitis B virus infections. , 1992, Ophthalmology.
[20] S. Holmberg,et al. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. , 1992, The New England journal of medicine.